Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for ZAP70 Deficiency (original) (raw)

References

  1. Chan AC, van Oers NS, Tran A, Turka L, Law CL, Ryan JC, et al. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. J Immunol. 1994;152(10):4758–66.
    CAS PubMed Google Scholar
  2. Au-Yeung BB, Deindl S, Hsu LY, Palacios EH, Levin SE, Kuriyan J, et al. The structure, regulation, and function of ZAP-70. Immunol Rev. 2009;228(1):41–57. doi:10.1111/j.1600-065X.2008.00753.x.
    Article CAS PubMed Google Scholar
  3. Arpaia E, Shahar M, Dadi H, Cohen A, Roifman CM. Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase. Cell. 1994;76(5):947–58.
    Article CAS PubMed Google Scholar
  4. Roifman CM, Hummel D, Martinez-Valdez H, Thorner P, Doherty PJ, Pan S, et al. Depletion of CD8+ cells in human thymic medulla results in selective immune deficiency. J Exp Med. 1989;170(6):2177–82.
    Article CAS PubMed Google Scholar
  5. Monafo WJ, Polmar SH, Neudorf S, Mather A, Filipovich AH. A hereditary immunodeficiency characterized by CD8+ T lymphocyte deficiency and impaired lymphocyte activation. Clin Exp Immunol. 1992;90(3):390–3.
    Article CAS PubMed PubMed Central Google Scholar
  6. Chan AY, Punwani D, Kadlecek TA, Cowan MJ, Olson JL, Mathes EF, et al. A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70. J Exp Med. 2016;213(2):155–65. doi:10.1084/jem.20150888.
    Article CAS PubMed PubMed Central Google Scholar
  7. Turul T, Tezcan I, Artac H, de Bruin-Versteeg S, Barendregt BH, Reisli I, et al. Clinical heterogeneity can hamper the diagnosis of patients with ZAP70 deficiency. Eur J Pediatr. 2009;168(1):87–93. doi:10.1007/s00431-008-0718-x.
    Article PubMed Google Scholar
  8. Newell A, Dadi H, Goldberg R, Ngan BY, Grunebaum E, Roifman CM. Diffuse large B-cell lymphoma as presenting feature of Zap-70 deficiency. J Allergy Clin Immunol. 2011;127(2):517–20. doi:10.1016/j.jaci.2010.09.016.
    Article PubMed Google Scholar
  9. Elder ME, Lin D, Clever J, Chan AC, Hope TJ, Weiss A, et al. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science. 1994;264(5165):1596–9.
    Article CAS PubMed Google Scholar
  10. Mazer B, Harbeck RJ, Franklin R, Schwinzer R, Kubo R, Hayward A, et al. Phenotypic features of selective T cell deficiency characterized by absence of CD8+ T lymphocytes and undetectable mRNA for ZAP-70 kinase. Clin Immunol Immunopathol. 1997;84(2):129–38.
    Article CAS PubMed Google Scholar
  11. Chan AC, Kadlecek TA, Elder ME, Filipovich AH, Kuo WL, Iwashima M, et al. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science. 1994;264(5165):1599–601.
    Article CAS PubMed Google Scholar
  12. Kim VH, Murguia L, Schechter T, Grunebaum E, Roifman CM. Emergency treatment for zeta chain-associated protein of 70 kDa (ZAP70) deficiency. J Allergy Clin Immunol. 2013;131(4):1233–5. doi:10.1016/j.jaci.2012.09.020.
    Article PubMed Google Scholar
  13. Akar HH, Patiroglu T, Akyildiz BN, Tekerek NU, Dogan MS, Doganay S, et al. Silent brain infarcts in two patients with zeta chain-associated protein 70 kDa (ZAP70) deficiency. Clin Immunol. 2015;158(1):88–91. doi:10.1016/j.clim.2015.03.014.
    Article PubMed Google Scholar
  14. Esenboga S, Ayvaz DC, Cetinkaya PG, van der Burg M, Tezcan I. An infant with ZAP-70 deficiency with disseminated mycobacterial disease. J Clin Immunol. 2016;36(2):103–6. doi:10.1007/s10875-015-0229-2.
    Article PubMed Google Scholar
  15. Hauck F, Blumenthal B, Fuchs S, Lenoir C, Martin E, Speckmann C, et al. SYK expression endows human ZAP70-deficient CD8 T cells with residual TCR signaling. Clin Immunol. 2015;161(2):103–9. doi:10.1016/j.clim.2015.07.002.
    Article CAS PubMed Google Scholar
  16. Karaca E, Karakoc-Aydiner E, Bayrak OF, Keles S, Sevli S, Barlan IB, et al. Identification of a novel mutation in ZAP70 and prenatal diagnosis in a Turkish family with severe combined immunodeficiency disorder. Gene. 2013;512(2):189–93. doi:10.1016/j.gene.2012.10.062.
    Article CAS PubMed Google Scholar
  17. Katamura K, Tai G, Tachibana T, Yamabe H, Ohmori K, Mayumi M, et al. Existence of activated and memory CD4+ T cells in peripheral blood and their skin infiltration in CD8 deficiency. Clin Exp Immunol. 1999;115(1):124–30.
    Article CAS PubMed PubMed Central Google Scholar
  18. Toyabe S, Watanabe A, Harada W, Karasawa T, Uchiyama M. Specific immunoglobulin E responses in ZAP-70-deficient patients are mediated by Syk-dependent T-cell receptor signalling. Immunology. 2001;103(2):164–71.
    Article CAS PubMed PubMed Central Google Scholar
  19. Elder ME, Skoda-Smith S, Kadlecek TA, Wang F, Wu J, Weiss A. Distinct T cell developmental consequences in humans and mice expressing identical mutations in the DLAARN motif of ZAP-70. J Immunol. 2001;166(1):656–61.
    Article CAS PubMed Google Scholar
  20. Picard C, Dogniaux S, Chemin K, Maciorowski Z, Lim A, Mazerolles F, et al. Hypomorphic mutation of ZAP70 in human results in a late onset immunodeficiency and no autoimmunity. Eur J Immunol. 2009;39(7):1966–76. doi:10.1002/eji.200939385.
    Article CAS PubMed Google Scholar
  21. Meinl E, Lengenfelder D, Blank N, Pirzer R, Barata L, Hivroz C. Differential requirement of ZAP-70 for CD2-mediated activation pathways of mature human T cells. J Immunol. 2000;165(7):3578–83.
    Article CAS PubMed Google Scholar
  22. Noraz N, Schwarz K, Steinberg M, Dardalhon V, Rebouissou C, Hipskind R, et al. Alternative antigen receptor (TCR) signaling in T cells derived from ZAP-70-deficient patients expressing high levels of Syk. J Biol Chem. 2000;275(21):15832–8. doi:10.1074/jbc.M908568199.
    Article CAS PubMed Google Scholar
  23. Honig M, Schuetz C, Schwarz K, Rojewski M, Jacobsen E, Lahr G, et al. Immunological reconstitution in a patient with ZAP-70 deficiency following transfusion of blood lymphocytes from a previously transplanted sibling without conditioning. Bone Marrow Transplant. 2012;47(2):305–7. doi:10.1038/bmt.2011.71.
    Article CAS PubMed Google Scholar
  24. Fagioli F, Biasin E, Berger M, Nesi F, Saroglia EH, Miniero R, et al. Successful unrelated cord blood transplantation in two children with severe combined immunodeficiency syndrome. Bone Marrow Transplant. 2003;31(2):133–6. doi:10.1038/sj.bmt.1703800.
    Article CAS PubMed Google Scholar
  25. Barata LT, Henriques R, Hivroz C, Jouanguy E, Paiva A, Freitas AM, et al. Primary immunodeficiency secondary to ZAP-70 deficiency. Acta Med Port. 2001;14(4):413–7.
    CAS PubMed Google Scholar
  26. Grazioli S, Bennett M, Hildebrand KJ, Vallance H, Turvey SE, Junker AK. Limitation of TREC-based newborn screening for ZAP70 severe combined immunodeficiency. Clin Immunol. 2014;153(1):209–10. doi:10.1016/j.clim.2014.04.015.
    Article CAS PubMed Google Scholar
  27. Grunebaum E, Mazzolari E, Porta F, Dallera D, Atkinson A, Reid B, et al. Bone marrow transplantation for severe combined immune deficiency. JAMA. 2006;295(5):508–18. doi:10.1001/jama.295.5.508.
    Article CAS PubMed Google Scholar
  28. Dalal I, Reid B, Doyle J, Freedman M, Calderwood S, Saunders F, et al. Matched unrelated bone marrow transplantation for combined immunodeficiency. Bone Marrow Transplant. 2000;25(6):613–21. doi:10.1038/sj.bmt.1702215.
    Article CAS PubMed Google Scholar
  29. Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, et al. Transplantation outcomes for severe combined immunodeficiency, 2000–2009. N Engl J Med. 2014;371(5):434–46. doi:10.1056/NEJMoa1401177.
    Article CAS PubMed PubMed Central Google Scholar
  30. Dvorak CC, Cowan MJ, Logan BR, Notarangelo LD, Griffith LM, Puck JM, et al. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. J Clin Immunol. 2013;33(7):1156–64. doi:10.1007/s10875-013-9917-y.
    Article CAS PubMed PubMed Central Google Scholar
  31. Shearer WT, Dunn E, Notarangelo LD, Dvorak CC, Puck JM, Logan BR, et al. Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol. 2014;133(4):1092–8. doi:10.1016/j.jaci.2013.09.044.
    Article PubMed Google Scholar
  32. Felgentreff K, Perez-Becker R, Speckmann C, Schwarz K, Kalwak K, Markelj G, et al. Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. Clin Immunol. 2011;141(1):73–82. doi:10.1016/j.clim.2011.05.007.
    Article CAS PubMed Google Scholar
  33. Soldin SJ, Brugnara C, Wong EC. Pediatric reference intervals. Sixthth ed. Washington: American Association for Clinical Chemistry Press; 2007.
    Google Scholar
  34. Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112(5):973–80. doi:10.1016/j.jaci.2003.07.003.
    Article PubMed Google Scholar
  35. van Gent R, van Tilburg CM, Nibbelke EE, Otto SA, Gaiser JF, Janssens-Korpela PL, et al. Refined characterization and reference values of the pediatric T- and B-cell compartments. Clin Immunol. 2009;133(1):95–107. doi:10.1016/j.clim.2009.05.020.
    Article PubMed Google Scholar
  36. Roifman CM, Somech R, Kavadas F, Pires L, Nahum A, Dalal I, et al. Defining combined immunodeficiency. J Allergy Clin Immunol. 2012;130(1):177–83. doi:10.1016/j.jaci.2012.04.029.
    Article CAS PubMed Google Scholar
  37. Murphy WJ, Kumar V, Bennett M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med. 1987;165(4):1212–7.
    Article CAS PubMed Google Scholar
  38. Haddad E, Leroy S, Buckley RH. B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment? J Allergy Clin Immunol. 2013;131(4):994–1000. doi:10.1016/j.jaci.2013.01.047.
    Article CAS PubMed PubMed Central Google Scholar
  39. Dvorak CC, Hassan A, Slatter MA, Honig M, Lankester AC, Buckley RH, et al. Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency. J Allergy Clin Immunol. 2014;134(4):935–43. doi:10.1016/j.jaci.2014.06.021. e15.
    Article PubMed PubMed Central Google Scholar
  40. Buckley RH. B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a review. J Allergy Clin Immunol. 2010;125(4):790–7. doi:10.1016/j.jaci.2010.02.012.
    Article CAS PubMed PubMed Central Google Scholar
  41. Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340(7):508–16. doi:10.1056/NEJM199902183400703.
    Article CAS PubMed Google Scholar
  42. Buckley RH, Win CM, Moser BK, Parrott RE, Sajaroff E, Sarzotti-Kelsoe M. Post-transplantation B cell function in different molecular types of SCID. J Clin Immunol. 2013;33(1):96–110. doi:10.1007/s10875-012-9797-6.
    Article CAS PubMed Google Scholar
  43. Brager R, Haynes A, Grunenbaum E, Hoenig M, Al-Mousa H, Al-Herz W et al. Presentation and outcome of Zap 70 deficiency [Abstract]. Biol Blood Marrow Transplant. [Abstract]. In press 2015.
  44. Jilkina O, Thompson JR, Kwan L, Van Caeseele P, Rockman-Greenberg C, Schroeder ML. Retrospective TREC testing of newborns with severe combined immunodeficiency and other primary immunodeficiency disorders. Mol Genet Metab Reports. 2014;1:324–33.
    Article CAS Google Scholar

Download references